Skip to content

Clinical trials

Adenocarcinoma of Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: Taiwan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20102
20123
20132
20151
20161
20202
20211
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
China Medical University Hospital2
National Taiwan University Hospital2
AstraZeneca1
Fu Jen Catholic University1
Lantern Pharma Inc.1
National Cheng-Kung University Hospital1
National Health Research Institutes, Taiwan1
Taipei Medical University Hospital1
Yuhan Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung17
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms9
Adenocarcinoma1
Breast Neoplasms1
Carcinoma, Ductal1
Colonic Neoplasms1
Colorectal Neoplasms1
Disease Progression1
Endometrial Neoplasms1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.